Image pharmaphorum Editor Partner Content Partner Content Understanding the Medical Continuum Building a full picture of the development of a drug can be a time-consuming process. Partner Content Partner Content “The important thing is to not stop questioning.” (Albert Ei... Intuition and experience – the ideal combination for finding a solution to an issue… or is it? Partner Content Partner Content Raising awareness of LHON for Rare Disease Day 2018 As Rare Disease Day approaches on 28 February, Santhera has created an infographic explaining the signs and symptoms of the rare disease Leber’s hereditary optic neuropathy (LHON), a progressive eye disease that results in blindness. Debates & Insight Sponsored Connecting the dots: Analysing the power of customer relatio... Load more results
Partner Content Partner Content Understanding the Medical Continuum Building a full picture of the development of a drug can be a time-consuming process.
Partner Content Partner Content “The important thing is to not stop questioning.” (Albert Ei... Intuition and experience – the ideal combination for finding a solution to an issue… or is it?
Partner Content Partner Content Raising awareness of LHON for Rare Disease Day 2018 As Rare Disease Day approaches on 28 February, Santhera has created an infographic explaining the signs and symptoms of the rare disease Leber’s hereditary optic neuropathy (LHON), a progressive eye disease that results in blindness.
News Roche culls myostatin candidate from obesity pipeline Roche has abandoned the development of one of its obesity candidates, emugrobart, and returned rights to originator Chugai Pharma.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
